Co-Target(s) Information
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T46365 | Target Info | |||
| Target Name | M-phase inducer phosphatase 2 (MPIP2) | ||||
| Synonyms |
Dual specificity phosphatase Cdc25B; Cdc25B phosphatase; CDC25HU2
Click to Show/Hide
|
||||
| Target Type | Clinical trial Target | ||||
| Gene Name | CDC25B | ||||
| Biochemical Class | Phosphoric monoester hydrolase | ||||
| UniProt ID | |||||
| Co-Targets of This Target | Top | |||||
|---|---|---|---|---|---|---|
| Co-Target Name | Indoleamine 2,3-dioxygenase 1 (IDO1) | Successful Target | ||||
| UniProt ID | I23O1_HUMAN | |||||
| Gene Name | IDO1 | |||||
| Synonyms |
Indoleamine-pyrrole 2,3-dioxygenase; INDO; IDO-1; IDO
Click to Show/Hide
|
|||||
| Representative Drug(s) | Avastin+/-Tarceva | Drug Info | IC50 = 1000 nM | [1] | ||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors. J Med Chem. 2008 Mar 27;51(6):1706-18. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.